Live tape
Top 8, mentions 7d10,067TSLA2,067 mentions▲ +0.05GOOGL1,609 mentions▲ +0.04NVDA1,231 mentions▲ +0.07CRWV1,216 mentions▲ +0.03SPCX1,103 mentions▲ +0.07QQQ1,076 mentions▲ +0.04META891 mentions▲ +0.05NBIS874 mentions▲ +0.06

Equity · Healthcare

IMCR

NASDAQ

Immunocore Holdings plc

$35 +2.94% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for IMCR to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $1.8B
52-week range $27.93 – $40
Avg volume 167.0K

as of Jul 17, 2026

IMCR insider trades

SEC Form 4

IMCR has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 18 February 2026.

Date Insider Type Shares Value
18 Feb 2026 Berman David M HEAD OF R&D Sell 5,965 $193K
18 Feb 2026 GOLL JOHN SVP, FINANCE & CAO Sell 698 $23K
18 Feb 2026 Jallal Bahija CHIEF EXECUTIVE OFFICER Sell 11,474 $371K
18 Feb 2026 St Leger Tina Amber CHIEF HR OFFICER Sell 1,000 $32K
05 Dec 2025 Berman David M HEAD OF R&D Sell 572 $23K
04 Dec 2025 Berman David M HEAD OF R&D Sell 31,341 $1.26M
28 Nov 2025 Berman David M HEAD OF R&D Sell 5,521 $221K
26 Nov 2025 Berman David M HEAD OF R&D Sell 69,404 $2.78M
25 Nov 2025 Berman David M HEAD OF R&D Sell 18,020 $721K
24 Nov 2025 Berman David M HEAD OF R&D Sell 100 $4K
30 Sep 2025 Berman David M HEAD OF R&D Sell 61,849 $2.18M
15 Sep 2025 Berman David M HEAD OF R&D Sell 200 $7K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
17 Feb 2026 Berman David M HEAD OF R&D Option exercise 11,824
17 Feb 2026 GOLL JOHN SVP, FINANCE & CAO Option exercise 1,351
17 Feb 2026 Jallal Bahija CHIEF EXECUTIVE OFFICER Option exercise 23,817
17 Feb 2026 St Leger Tina Amber CHIEF HR OFFICER Option exercise 2,119
05 Dec 2025 Berman David M HEAD OF R&D Option exercise 572 $10K
04 Dec 2025 Berman David M HEAD OF R&D Option exercise 31,341 $547K
28 Nov 2025 Berman David M HEAD OF R&D Option exercise 5,521 $96K
26 Nov 2025 Berman David M HEAD OF R&D Option exercise 69,404 $1.21M
25 Nov 2025 Berman David M HEAD OF R&D Option exercise 18,020 $315K
24 Nov 2025 Berman David M HEAD OF R&D Option exercise 100 $2K
30 Sep 2025 Berman David M HEAD OF R&D Option exercise 61,849 $1.08M
15 Sep 2025 Berman David M HEAD OF R&D Option exercise 200 $3K

IMCR reported financials

SEC EDGAR XBRL SEC EDGAR

IMCR reported revenue of $400.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$35.5M.

Figure Reported Period
Revenue $400.0M 31 Dec 2025 fiscal year
Net income −$35.5M 31 Dec 2025 fiscal year
Diluted EPS −$0.71 31 Dec 2025 fiscal year
Total assets $1.1B 30 Jun 2026 at period end
Total equity $419.8M 30 Jun 2026 at period end

IMCR earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.02 —
31 Mar 2026 Q1 2026 $0.25 —
31 Dec 2025 FY 2025 −$0.71 —
30 Sep 2025 Q3 2025 $0.00 —
30 Jun 2025 Q2 2025 −$0.20 —
31 Mar 2025 Q1 2025 $0.10 —
31 Dec 2024 FY 2024 −$1.02 —
30 Sep 2024 Q3 2024 $0.17 $80M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

IMCR institutional holders

SEC Form 13F SEC EDGAR

8 of the 45 institutional funds we track reported a IMCR position for the quarter ended 30 Jun 2026 — a combined $188.5M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Two Sigma Investments Added +61.5% shares 1,648,983 $52.4M
Millennium Management Added +29.1% shares 1,597,037 $50.7M
Point72 Asset Management Held (±25%) −10.2% shares 990,280 $31.4M
Marshall Wace Added +227.7% shares 590,941 $18.8M
Citadel Advisors Added +146.0% shares 566,761 $18.0M
D. E. Shaw & Co. Held (±25%) +20.9% shares 405,116 $12.9M
Renaissance Technologies Trimmed −37.6% shares 102,400 $3.3M
Bridgewater Associates Added +93.9% shares 36,707 $1.2M
Baker Bros. Advisors Exited
Balyasny Asset Management Exited

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SEC EDGARValuation computed from SEC EDGAR filings